Login Register Cart 0
Generic placeholder image

Current Radiopharmaceuticals

Editor-in-Chief

ISSN (Print): 1874-4710
ISSN (Online): 1874-4729

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

The Impact of HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) on the Psychological Well-being of Gynecological Cancer Patients

Author(s): Luca Tagliaferri, Silvia Mancini, Valentina Lancellotta*, Loredana Dinapoli, Nikola Capocchiano, Patrizia Cornacchione, Sara Scalise, Rosa Autorino, Maura Campitelli, Giuseppe Ferdinando Colloca, Bruno Fionda, Angeles Rovirosa, Gabriella Macchia, Gabriella Ferrandina and Maria Antonietta Gambacorta

Volume 17, Issue 2, 2024

Published on: 02 October, 2023

Page: [168 - 173] Pages: 6

DOI: 10.2174/0118744710247426230925054848

Price: $65

Abstract

Background: HAPPY (Humanity Assurance Protocol in Interventional Radiotherapy) reports the necessity for gynecological cancer patients to undergo interventional radiotherapy (IRT, also called brachytherapy). The present paper has evaluated how some precautions may improve the psychological well-being of the patients during IRT.

Methods: Patients with gynecological cancer undergoing IRT-HDR were analyzed. Patients answered three questionnaires before the IRT procedure (T0) and at the end of IRT (T1): Distress Thermometer (DT), Numerical Rating Scale for IRT procedure distress (NRS), and Hospital Anxiety and Depression Scale (HADS). Correlations have been calculated pairwise through pandas. corrwith with a Pearson algorithm, and the p-values have been calculated through scipy.stats.pearsonr. Plots have been generated through seaborn and matplotlib. A Wilcoxon test was used.

Results: 55 patients were selected for this study. The median age of the patients was 64 (range, 39-84) years. 52 patients were with stage I endometrial cancer, whereas 3/3 patients with cervical cancer had locally advanced stages (IIB-IVA). 26 patients had a high education level (47.3%), and 38 were married or with a partner (69.1%). Only 14/55 (25.45%) patients were working. The HADS, DT, and NRS averages before the IRT procedure (T0) were 10.2, 3.8, and 4.3, respectively. After applying the HAPPY protocol, the HADS, DT, and NRS averages after IRT (T1) were 9.4, 3.4, and 2.6, respectively. The Wilcoxon signed rank test analysis showed a significant improvement in NRS (p < 0.00001) and HADS (p = 0.034). Living with a partner, parents or relatives was the only parameter statistically significantly associated with better DT pre-IRT (p = 0.04), HADS pre-IRT (p = 0.01), DT post-IRT (p = 0.01), and HADS post-IRT (p = 0.04).

Conclusion: In our study, the HAPPY protocol was associated with a significant reduction in patients’ distress, anxiety, and discomfort.

« Previous Next »
[1]
Rossetti, A.; Chadha, M.; Torres, B.N.; Lee, J.K.; Hylton, D.; Loewy, J.V.; Harrison, L.B. The Impact of music therapy on anxiety in cancer patients undergoing simulation for radiation therapy. Int. J. Radiat. Oncol. Biol. Phys., 2017, 99(1), 103-110.
[http://dx.doi.org/10.1016/j.ijrobp.2017.05.003] [PMID: 28816136]
[2]
Guo, Z.; Tang, H.; Li, H.; Tan, S.; Feng, K.; Huang, Y.; Bu, Q.; Jiang, W. The benefits of psychosocial interventions for cancer patients undergoing radiotherapy. Health Qual. Life Outcomes, 2013, 11(1), 121.
[http://dx.doi.org/10.1186/1477-7525-11-121] [PMID: 23866850]
[3]
Andersen, B.L.; Yang, H.C.; Farrar, W.B.; Golden-Kreutz, D.M.; Emery, C.F.; Thornton, L.M.; Young, D.C.; Carson, W.E., III Psychologic intervention improves survival for breast cancer patients. Cancer, 2008, 113(12), 3450-3458.
[http://dx.doi.org/10.1002/cncr.23969] [PMID: 19016270]
[4]
Vetter, D.; Barth, J.; Uyulmaz, S.; Uyulmaz, S.; Vonlanthen, R.; Belli, G.; Montorsi, M.; Bismuth, H.; Witt, C.M.; Clavien, P.A. Effects of art on surgical patients: A systematic review and metaanalysis. Ann. Surg., 2015, 262(5), 704-713.
[http://dx.doi.org/10.1097/SLA.0000000000001480] [PMID: 26583656]
[5]
Tagliaferri, L.; Kovács, G.; Aristei, C.; De Sanctis, V.; Barbera, F.; Morganti, A.G.; Casà, C.; Pieters, B.R.; Russi, E.; Livi, L.; Corvò, R.; Giovagnoni, A.; Ricardi, U.; Valentini, V.; Magrini, S.M. Current state of interventional radiotherapy (brachytherapy) education in Italy: Results of the INTERACTS survey. J. Contemp. Brachytherapy, 2019, 11(1), 48-53.
[http://dx.doi.org/10.5114/jcb.2019.83137] [PMID: 30911310]
[6]
Schulman-Green, D.; Bradley, E.H.; Nicholson, N.R., Jr; George, E.; Indeck, A.; McCorkle, R. One step at a time: Self-management and transitions among women with ovarian cancer. Oncol. Nurs. Forum, 2012, 39(4), 354-360.
[http://dx.doi.org/10.1188/12.ONF.354-360] [PMID: 22750893]
[7]
Lancellotta, V.; Kovács, G.; Tagliaferri, L. The role of personalized Interventional Radiotherapy (brachytherapy) in the management of older patients with non-melanoma skin cancer. J. Geriatr. Oncol., 2018, S1879-4068(18, 30259-5.
[PMID: 30314955]
[8]
Andersen, M.R.; Sweet, E.; Lowe, K.A.; Standish, L.J.; Drescher, C.W.; Goff, B.A. Involvement in decision-making about treatment and ovarian cancer survivor quality of life. Gynecol. Oncol., 2012, 124(3), 465-470.
[http://dx.doi.org/10.1016/j.ygyno.2011.10.029] [PMID: 22044688]
[9]
Luketina, H.; Fotopoulou, C.; Luketina, R.R.; Pilger, A.; Sehouli, J. Treatment decision-making processes in the systemic treatment of ovarian cancer: Review of the scientific evidence. Anticancer Res., 2012, 32(9), 4085-4090.
[PMID: 22993365]
[10]
Stewart, D.E.; Wong, F.; Cheung, A.M.; Dancey, J.; Meana, M.; Cameron, J.I.; McAndrews, M.P.; Bunston, T.; Murphy, J.; Rosen, B. Information needs and decisional preferences among women with ovarian cancer. Gynecol. Oncol., 2000, 77(3), 357-361.
[http://dx.doi.org/10.1006/gyno.2000.5799] [PMID: 10831342]
[11]
Howell, D.; Fitch, M.I.; Deane, K.A. Impact of ovarian cancer perceived by women. Cancer Nurs., 2003, 26(1), 1-9.
[http://dx.doi.org/10.1097/00002820-200302000-00001] [PMID: 12556707]
[12]
Jenkins, V.; Catt, S.; Banerjee, S.; Gourley, C.; Montes, A.; Solis-Trapala, I.; Monson, K.; Fallowfield, L. Patients’ and oncologists’ views on the treatment and care of advanced ovarian cancer in the UK: Results from the ADVOCATE study. Br. J. Cancer, 2013, 108(11), 2264-2271.
[http://dx.doi.org/10.1038/bjc.2013.223] [PMID: 23652312]
[13]
Husson, O.; Mols, F.; van de Poll-Franse, L.V. The relation between information provision and health-related quality of life, anxiety and depression among cancer survivors: A systematic review. Ann. Oncol., 2011, 22(4), 761-772.
[http://dx.doi.org/10.1093/annonc/mdq413] [PMID: 20870912]
[14]
Lancellotta, V.; De Sanctis, V.; Cornacchione, P.; Barbera, F.; Fusco, V.; Vidali, C.; Scalise, S.; Panza, G.; Tenore, A.; Colloca, G.; Corvò, R.; Gambacorta, M.; Magrini, S.; Tagliaferri, L. HAPPY-Humanity Assurance Protocol in interventional radiotheraPY (brachytherapy)-an AIRO Interventional Radiotherapy Study Group project. J. Contemp. Brachytherapy, 2019, 11(6), 510-515.
[http://dx.doi.org/10.5114/jcb.2019.91222] [PMID: 31969908]
[15]
Costanzo, E.S.; Lutgendorf, S.K.; Rothrock, N.E.; Anderson, B. Coping and quality of life among women extensively treated for gynecologic cancer. Psychooncology, 2006, 15(2), 132-142.
[http://dx.doi.org/10.1002/pon.930] [PMID: 15880387]
[16]
Tabano, M.; Condosta, D.; Coons, M. Symptoms affecting quality of life in women with gynecologic cancer. Semin. Oncol. Nurs., 2002, 18(3), 223-230.
[http://dx.doi.org/10.1053/sonu.2002.34084] [PMID: 12184045]
[17]
Grassi, L.; Johansen, C.; Annunziata, M.A.; Capovilla, E.; Costantini, A.; Gritti, P.; Torta, R.; Bellani, M. Italian society of psychooncology distress thermometer study group. Screening for distress in cancer patients. Cancer, 2013, 119(9), 1714-1721.
[http://dx.doi.org/10.1002/cncr.27902] [PMID: 23423789]
[18]
Zigmond, A.S.; Snaith, R.P. The hospital anxiety and depression scale. Acta Psychiatr. Scand., 1983, 67(6), 361-370.
[http://dx.doi.org/10.1111/j.1600-0447.1983.tb09716.x] [PMID: 6880820]
[19]
Fang, P.; Tan, K.S.; Grover, S.; McFadien, M.K.; Troxel, A.B.; Lin, L. Psychosocial encounters correlates with higher patientreported functional quality of life in gynecological cancer patients receiving radiotherapy. Radiat. Oncol., 2015, 10(1), 34.
[http://dx.doi.org/10.1186/s13014-015-0339-2] [PMID: 25657054]
[20]
Pearman, T. Quality of life and psychosocial adjustment in gynecologic cancer survivors. Health Qual. Life Outcomes, 2003, 1(1), 33.
[http://dx.doi.org/10.1186/1477-7525-1-33] [PMID: 12952541]
[21]
Hodgkinson, K.; Butow, P.; Fuchs, A.; Hunt, G.E.; Stenlake, A.; Hobbs, K.M.; Brand, A.; Wain, G. Long-term survival from gynecologic cancer: Psychosocial outcomes, supportive care needs and positive outcomes. Gynecol. Oncol., 2007, 104(2), 381-389.
[http://dx.doi.org/10.1016/j.ygyno.2006.08.036] [PMID: 17027072]
[22]
Kirchheiner, K.; Czajka-Pepl, A.; Ponocny-Seliger, E.; Scharbert, G.; Wetzel, L.; Nout, R.A.; Sturdza, A.; Dimopoulos, J.C.; Dörr, W.; Pötter, R. Posttraumatic stress disorder after high-dose-rate brachytherapy for cervical cancer with 2 fractions in 1 application under spinal/epidural anesthesia: Incidence and risk factors. Int. J. Radiat. Oncol. Biol. Phys., 2014, 89(2), 260-267.
[http://dx.doi.org/10.1016/j.ijrobp.2014.02.018] [PMID: 24721589]
[23]
Lancellotta, V.; Macchia, G.; Dinapoli, N.; Autorino, R.; Campitelli, M.; Nardangeli, A.; Salvati, A.; Fionda, B.; Casà, C.; Cornacchione, P.; Rovirosa, A.; Kovács, G.; Morganti, A.G.; Ferrandina, M.G.; Gambacorta, M.A.; Tagliaferri, L. EROS 2.0 study: Evaluation of two interventional radiotherapy (brachytherapy) schedules for endometrial cancer: a comparison of late vaginal toxicity rates. Radiol. Med., 2022, 127(3), 341-348.
[http://dx.doi.org/10.1007/s11547-022-01455-y] [PMID: 35092552]
[24]
Tagliaferri, L.; Vavassori, A.; Lancellotta, V.; De Sanctis, V.; Barbera, F.; Fusco, V.; Vidali, C.; Fionda, B.; Colloca, G.; Gambacorta, M.; Aristei, C.; Corvò, R.; Magrini, S. Can brachytherapy be properly considered in the clinical practice? Trilogy project: The vision of the AIRO (Italian Association of Radiotherapy and Clinical Oncology) Interventional Radiotherapy study group. J. Contemp. Brachytherapy, 2020, 12(1), 84-90.
[http://dx.doi.org/10.5114/jcb.2020.92765] [PMID: 32190074]
[25]
Balducci, M.; Fiorentino, A.; De Bonis, P.; Chiesa, S.; Manfrida, S.; D’Agostino, G.R.; Mantini, G.; Frascino, V.; Mattiucci, G.C.; De Bari, B.; Mangiola, A.; Miccichè, F.; Gambacorta, M.A.; Colicchio, G.; Morganti, A.G.; Anile, C.; Valentini, V. Impact of age and co-morbidities in patients with newly diagnosed glioblastoma: A pooled data analysis of three prospective mono-institutional phase II studies. Med. Oncol., 2012, 29(5), 3478-3483.
[http://dx.doi.org/10.1007/s12032-012-0263-3] [PMID: 22674154]
[26]
Ferrandina, G.; Gambacorta, A.; Gallotta, V.; Smaniotto, D.; Fagotti, A.; Tagliaferri, L.; Foti, E.; Fanfani, F.; Autorino, R.; Scambia, G.; Valentini, V. Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: Long-term results of the ROMA-2 prospective phase 2 study. Int. J. Radiat. Oncol. Biol. Phys., 2014, 90(4), 778-785.
[http://dx.doi.org/10.1016/j.ijrobp.2014.07.033] [PMID: 25585781]
[27]
Jereczek-Fossa, B.A.; Pepa, M.; Marvaso, G.; Bruni, A.; Buglione di Monale e Bastia, M.; Catalano, G.; Filippi, A.R.; Franco, P.; Gambacorta, M.A.; Genovesi, D.; Iatì, G.; Magli, A.; Marafioti, L.; Meattini, I.; Merlotti, A.; Mignogna, M.; Musio, D.; Pacelli, R.; Pergolizzi, S.; Tombolini, V.; Trovò, M.; Ricardi, U.; Magrini, S.M.; Corvò, R.; Donato, V. COVID-19 outbreak and cancer radiotherapy disruption in Italy: Survey endorsed by the Italian Association of Radiotherapy and Clinical Oncology (AIRO). Radiother. Oncol., 2020, 149, 89-93.
[http://dx.doi.org/10.1016/j.radonc.2020.04.061] [PMID: 32413527]
[28]
Tagliaferri, L.; Gobitti, C.; Colloca, G.F.; Boldrini, L.; Farina, E.; Furlan, C.; Paiar, F.; Vianello, F.; Basso, M.; Cerizza, L.; Monari, F.; Simontacchi, G.; Gambacorta, M.A.; Lenkowicz, J.; Dinapoli, N.; Lanzotti, V.; Mazzarotto, R.; Russi, E.; Mangoni, M. A new standardized data collection system for interdisciplinary thyroid cancer management: Thyroid COBRA. Eur. J. Intern. Med., 2018, 53, 73-78.
[http://dx.doi.org/10.1016/j.ejim.2018.02.012] [PMID: 29477755]
[29]
León-Pizarro, C.; Gich, I.; Barthe, E.; Rovirosa, A.; Farrús, B.; Casas, F.; Verger, E.; Biete, A.; Craven-Bartle, J.; Sierra, J.; Arcusa, A. A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and qualityof-life indices for gynecologic and breast brachytherapy patients. Psychooncology, 2007, 16(11), 971-979.
[http://dx.doi.org/10.1002/pon.1171] [PMID: 17311247]
[30]
Luebbert, K.; Dahme, B.; Hasenbring, M. The effectiveness of relaxation training in reducing treatment-related symptoms and improving emotional adjustment in acute non-surgical cancer treatment: A meta-analytical review. Psychooncology, 2001, 10(6), 490-502.
[http://dx.doi.org/10.1002/pon.537] [PMID: 11747061]
[31]
Balderson, N.; Towell, T. The prevalence and predictors of psychological distress in men with prostate cancer who are seeking support. Br. J. Health Psychol., 2003, 8(2), 125-134.
[http://dx.doi.org/10.1348/135910703321649114] [PMID: 12804328]

Rights & Permissions Print Cite
© 2024 Bentham Science Publishers | Privacy Policy